In Brief: Endocare
This article was originally published in The Gray Sheet
Executive Summary
Endocare: Receives 510(k) clearance for its TEMPprobes temperature monitoring devices. The devices, which list at $80 per probe, are designed for use in conjunction with most cryotherapy systems, such as the firm's CRYOcare system for monitoring temperature of prostate tissue targeted for cryoablation. Surgeons normally use five probes per procedure, the company says. Endocare is working to expand labeling for the CRYOcare system to include use in other urologic applications...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.